CONIFY IKE

Their core work

CONIFY IKE is a Greek technology SME operating at the intersection of advanced manufacturing processes and materials characterization. Their work covers injection moulding, additive manufacturing (3D printing), and nanomechanical testing, with demonstrated ability to apply industrial manufacturing expertise to medical and health supply contexts. In the nanoMECommons project they contribute to EU-wide harmonization of nanomechanics protocols and data exchange standards — suggesting a metrology or testing-equipment capability rather than pure production. The imPURE project, launched in 2020, focused on repurposing injection moulding lines to produce medical supplies using additive manufacturing — likely a COVID-19-response initiative.

What they specialise in

How they've shifted over time

With only two projects — both starting within a year of each other (2020-2021) — there is insufficient history to trace a meaningful long-term evolution. What can be said is that their entry into H2020 funding began with a reactive, application-driven project (rapid manufacturing of medical supplies) and quickly extended into a longer-horizon standards project (nanomechanics protocols through 2025). This suggests a company moving from applied problem-solving toward deeper involvement in EU research infrastructure and technical governance.

CONIFY IKE appears to be broadening from contract manufacturing applications toward EU-level technical standardisation, which would position them as a credible contributor to future materials testing and metrology consortia.

How they like to work

CONIFY IKE has participated exclusively as a partner, never as project coordinator, across both funded projects. Despite this, they have accumulated 38 unique consortium partners across 12 countries from just two projects — indicating involvement in large, multi-stakeholder consortia rather than small bilateral collaborations. This profile suggests they bring a specific technical contribution that larger consortia seek out, rather than driving project strategy themselves.

With 38 unique partners across 12 countries from only two projects, CONIFY IKE's network is disproportionately wide for their project volume. This points to participation in large pan-European research consortia with broad geographic coverage.

What sets them apart

CONIFY IKE occupies an unusual niche as a small Greek private company with simultaneous credibility in both precision manufacturing process engineering and nanoscale materials characterisation — two disciplines that rarely overlap in a single SME. Their participation in a 2025-running RIA on nanomechanics protocol harmonisation gives them a foothold in EU metrology governance that most manufacturing SMEs lack. For consortium builders needing a Southern European industrial SME with materials testing know-how, they are a practical and uncommon choice.

Highlights from their portfolio

• nanoMECommons
  Longest-running project (through 2025) with the highest EC contribution (€406,800), focused on EU-wide harmonisation of nanomechanics testing protocols — a rare standards-infrastructure role for an SME.
• imPURE
  A 2020 Innovation Action that applied injection moulding and additive manufacturing to medical supply production, likely in response to pandemic-driven demand — demonstrating rapid industrial adaptability.